Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
24-26 February, 2026
Not Confirmed
Not Confirmed
21-22 January, 2026
Not Confirmed
Not Confirmed
27-29 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 February, 2026
Industry Trade Show
Not Confirmed
21-22 January, 2026
Industry Trade Show
Not Confirmed
27-29 January, 2026
Digital content

05 Apr 2016
// IN PHARMATECHNOLOGIST
http://www.in-pharmatechnologist.com/Ingredients/Aesica-adds-dev-stage-formulation-capabilities-for-potent-APIs-and-controlled-drugs
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9087
Submission : 1991-04-29
Status : Active
Type : II
Certificate Number : R1-CEP 2012-280 - Rev 00
Issue Date : 2019-04-11
Type : Chemical
Substance Number : 1673
Status : Withdrawn by Holder

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
Registration Number : 218MF10003
Registrant's Address : Queenborough, Kent ME11 5EL, United Kingdom
Initial Date of Registration : 2006-01-06
Latest Date of Registration :

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
ABOUT THIS PAGE
Aesica Queenborough Limited is a supplier offers 2 products (APIs, Excipients or Intermediates).
Find a price of Isoflurane bulk with DMF offered by Aesica Queenborough Limited
Find a price of Levobupivacaine bulk with JDMF offered by Aesica Queenborough Limited